Frequency and Clinical Implications of Discordant Creatine Kinase-MB and Troponin Measurements in Acute Coronary Syndromes
L. Kristin Newby(Duke University), Eric D. Peterson, Charles V. Pollack, Matthew T. Roe(Clinical Research Institute), Robert A. Harrington(Clinical Research Institute), Anita Y. Chen(University of Rochester Medicine), E. Magnus Ohman(Office of Science), Robert L. Jesse(Virginia Commonwealth University Medical Center), James W. Hoekstra(Wake Forest University), Robert H. Christenson(University of Maryland, Baltimore), W. Brian Gibler(University of Cincinnati), W. Frank Peacock(Hennepin Healthcare Research Institute)
Cited by 75
Related Papers
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
|Journal of the American College of Cardiology|2014|3.6k
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
|New England Journal of Medicine|2018|3.5k
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
|The Lancet|2018|1.8k
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease
|Journal of the American College of Cardiology|2016|1.6k